#pharmalicensingdeals #pharmaceuticalassets #VirBiotech #Vir #HarbourBioMed #UnnaturalProducts #Genhouse #CSL #Astellas #SolsticeOncology #antiCTLA4antibody #Novartis #UnnaturalProducts #macrocyclicpeptidedrugs #GileadSciences #syntheticlethality #GenhouseBio #Arcellx #EliLilly
zurl.co/HOdjt
zurl.co/HOdjt
Astellas bets on Vir cancer drug, and other licensing deals
Our latest round-up of pharma licensing deals features assets from Vir Biotech, Harbour BioMed, Unnatural Products, Genhouse, and CSL.
zurl.co
February 25, 2026 at 12:05 PM
#BristolMyersSquibb #Sanofi #Pfizer #Roche #YarrowBioscience #RandDpipelines #HarbourBioMed #Genentech #AI #CarisLifeSciences #CarisDiscovery #ADEL #phase1testing #DrenBio #drugdiscovery #immunology #oncology #rheumatology #Gravesdisease #GeneSciencePharma #GenSci
zurl.co/Kyjjn
zurl.co/Kyjjn
As year-end nears, pharma groups plump up their pipelines
Bristol Myers Squibb, Sanofi, Pfizer, Roche, and Yarrow Bioscience all added to their pipelines this week in an end-of-year licensing deal flurry.
pharmaphorum.com
December 19, 2025 at 11:04 AM
Our latest round-up of #pharmalicensing deals features assets from #VirBiotech, #HarbourBioMed, #UnnaturalProducts, #Genhouse, and #CSL.
pharmaphorum.com/news/astella...
pharmaphorum.com/news/astella...
February 25, 2026 at 10:59 AM
Our latest round-up of #pharmalicensing deals features assets from #VirBiotech, #HarbourBioMed, #UnnaturalProducts, #Genhouse, and #CSL.
pharmaphorum.com/news/astella...
pharmaphorum.com/news/astella...